The global pharmacovigilance market size reached US$ 6.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2027, exhibiting a CAGR of 10.5% during 2022-2027. More Info:- https://www.imarcgroup.com/pharmacovigilance-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Pharmacovigilance Market
Research and Forecast Report 2022-
2027
Author: Elena Anderson
Marketing Manager
IMARC Group
© 2022 IMARC All Rights Reserved

2. Report Description
About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all regions
and industry verticals to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Pharmacovigilance Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled "Pharmacovigilance Market: Global Industry
Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global pharmacovigilance
market size reached US$ 6.7 Billion in 2021.
Pharmacovigilance (PV) is the pharmacological science of studying the detection, assessment, and
prevention of unfavorable effects of pharmaceutical medicines. It plays a critical role in identifying
previously unknown ADR (adverse drug reactions) and drug toxicity, determining changes in
frequency or severity, and assessing the risks and benefits of drugs to determine required actions.
It also assures the accuracy of communicated information to healthcare professionals and patients.
As a result, PV is widely used to comprehend the effects of drugs on individuals across the globe.
Request for a PDF sample of this report: https://www.imarcgroup.com/pharmacovigilance-
market/requestsample

4. Report Description
Report Description and Highlights
Global Pharmacovigilance Market Trends:
The market is primarily driven by the rising prevalence of chronic diseases, such as diabetes,
hypertension, oncological diseases, and cardiac disorders, resulting in the increasing consumption of
drugs worldwide. In addition, the introduction of advanced platforms to ensure automated ADR
reporting is contributing to market growth. Moreover, the sudden outbreak of coronavirus disease
(COVID-19) and the consequent necessity for vaccination has also created several opportunities for the
market players. This, coupled with the widespread adoption of new technologies in clinical research,
such as the incorporation of virtual services in the clinical trial protocol, is augmenting the market
growth.
Besides this, leading companies are undertaking various initiatives to conduct clinical trials and generate
awareness about the proper utilization of medicines, which is facilitating the market growth. Along with
this, extensive research and development (R&D) activities conducted by major pharmaceutical and
biotechnological companies to develop new drugs are providing a positive thrust to the market growth.
Looking forward, IMARC Group expects the market value to reach US$ 11.8 Billion by 2027, exhibiting
a CAGR of 10.5% during the forecast period (2022-2027).
View Report TOC, Figures and Tables: https://www.imarcgroup.com/pharmacovigilance-market

5. Report Description
Report Description and Highlights
Key Market Segmentation
The research report includes the following segments:
Breakup by Service Provider:
•In-house
•Contract Outsourcing
Breakup by Product Life Cycle:
•Pre-clinical
•Phase I
•Phase II
•Phase III
•Phase IV
Breakup by Type:
•Spontaneous Reporting
•Intensified ADR Reporting
•Targeted Spontaneous Reporting
•Cohort Event Monitoring
•EHR Mining

6. Report Description
Report Description and Highlights
Breakup by Process Flow:
•Case Data Management
• Case Logging
• Case Data Analysis
• Medical Reviewing and Reporting
•Signal Detection
• Adverse Event Logging
• Adverse Event Analysis
• Adverse Event Review and Reporting
•Risk Management System
• Risk Evaluation System
• Risk Mitigation System
Breakup by Therapeutic Area:
•Oncology
•Neurology
•Cardiology
•Respiratory Systems
•Others

7. Report Description
Report Description and Highlights
Breakup by End Use:
•Pharmaceuticals Companies
•Biotechnology Companies
•Medical Device Companies
•Others
Breakup by Region:
•North America
•Asia Pacific
•Europe
•Latin America
•Middle East and Africa

8. Report Description
Report Description and Highlights
Competitive Landscape with Key Players:
•Accenture plc
•ArisGlobal LLC
•BioClinica Inc. (Cinven Partners LLP)
•Capgemini
•Cognizant
•International Business Machines Corporation
•ICON plc
•IQVIA Inc
•ITClinical
•Parexel International Corporation
•Wipro Limited

9. Report Description
Key Questions Answered in the Report
1. How has the global pharmacovigilance market performed so far and how will it perform in the
coming years?
2. What has been the impact of COVID-19 on the global pharmacovigilance market?
3. What are the key regional markets?
4. What is the breakup of the market based on the service provider?
5. What is the breakup of the market based on the product life cycle?
6. What is the breakup of the market based on the type?
7. What is the breakup of the market based on the process flow?
8. What is the breakup of the market based on the therapeutic area?
9. What is the breakup of the market based on the end use?
10. What are the various stages in the value chain of the industry?
11. What are the key driving factors and challenges in the industry?
12. What is the structure of the global pharmacovigilance market and who are the key players?
13. What is the degree of competition in the industry?

10. Report Description Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pharmacovigilance Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

11. Report Description Table of Contents
6 Market Breakup by Service Provider
6.1 In-house
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Contract Outsourcing
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Product Life Cycle
7.1 Pre-clinical
7.1.1 Market Trends
7.1.2 Market Forecast
7.1 Phase I
7.1.1 Market Trends
7.1.2 Market Forecast
7.1 Phase II
7.1.1 Market Trends
7.1.2 Market Forecast
Click here to visit the complete table of content with list of figures and tables:
https://www.imarcgroup.com/pharmacovigilance-market/toc

12. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

13. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

14. Report Description
Report Description and Highlights
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

15. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us